ALK-Abelló A/S (CPH:ALK.B)
Denmark · Delayed Price · Currency is DKK 228.20
-1.60 (-0.70%)
At close: Jan 8, 2026
ALK-Abelló Market Cap
ALK-Abelló has a market cap or net worth of 50.48 billion as of January 9, 2026. Its market cap has increased by 47.32% in one year.
Market Cap
50.48B
Enterprise Value
50.27B
Revenue
6.08B
Ranking
n/a
PE Ratio
45.87
Stock Price
228.20
Market Cap Chart
Since December 27, 2005, ALK-Abelló's market cap has increased from 6.91B to 50.48B, an increase of 630.68%. That is a compound annual growth rate of 10.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 8, 2026 | 50.48B | -0.17% |
| Dec 30, 2025 | 50.56B | 43.68% |
| Dec 30, 2024 | 35.19B | 57.21% |
| Dec 29, 2023 | 22.38B | 5.48% |
| Dec 30, 2022 | 21.22B | -43.63% |
| Dec 30, 2021 | 37.65B | 37.96% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.65T |
| Genmab | 132.44B |
| Coloplast | 127.06B |
| Demant | 47.25B |
| H. Lundbeck | 42.88B |
| Zealand Pharma | 29.89B |
| Ambu A/S | 23.56B |
| GN Store Nord | 16.26B |